assess novel molecules based on target inputs rather than extensive empirical screening. Its technology is applied to design antibodies and other molecular candidates with desired properties to help accelerate research and therapeutic development workflows. Chai Discovery partners with scientific and pharmaceutical teams to integrate its AI tools into discovery pipelines and expand access to computational design capabilities.